Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients
This study has been completed.
Study NCT00239798   Information provided by Novartis

First Received on October 13, 2005.   Last Updated on November 1, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Renal Transplantation
Interventions listed in this trial
FTY720
Additional drug interventions recognized in this trial
Fingolimod
More general drug interventions related to this trial
Immunologic Factors
Immunosuppressive Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Novartis Pharmaceuticals
Mitsubishi Tanabe Pharma Corporation


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services